- Home
- NSA vs DYN Comparison
NSA vs DYN Comparison
Compare NSA & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | DYN |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | 1458 | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NSA | DYN |
|---|---|---|
| Price | $42.00 | $17.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | $34.38 | ★ $37.00 |
| AVG Volume (30 Days) | 923.9K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.39 | N/A |
| P/E Ratio | $56.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.43 | $8.25 |
| 52 Week High | $44.02 | $25.00 |
Technical Indicators
Market Signals| Indicator | NSA | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 41.91 |
| Support Level | $27.89 | $16.47 |
| Resistance Level | $44.02 | $19.65 |
| Average True Range (ATR) | 1.02 | 0.90 |
| MACD | -0.36 | -0.27 |
| Stochastic Oscillator | 27.39 | 9.58 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.